Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Conditions
Atopic Dermatitis (AD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Enveda Investigative Site, Birmingham, Alabama, United States
Enveda Investigative Site, Hot Springs, Arkansas, United States
Enveda Investigative Site, Beverly Hills, California, United States
Enveda Investigative Site, Fremont, California, United States
Enveda Investigative Site, San Diego, California, United States
Enveda Investigative Site, San Diego, California, United States
Enveda Investigative Site, West Hills, California, United States
Enveda Investigative Site, Atlanta, Georgia, United States
Enveda Investigative Site, New Albany, Indiana, United States
Enveda Investigative Site, West Lafayette, Indiana, United States
Enveda Investigative Site, Louisville, Kentucky, United States
Enveda Investigative Site, Auburn Hills, Michigan, United States
Enveda Investigative Site, Bay City, Michigan, United States
Enveda Investigative Site, Clinton Township, Michigan, United States
Enveda Investigative Site, Warren, Michigan, United States
Enveda Investigative Site, Las Vegas, Nevada, United States
Enveda Investigative Site, Canton, Ohio, United States
Enveda Investigative Site, Mayfield Heights, Ohio, United States
Enveda Investigative Site, Camp Hill, Pennsylvania, United States
Enveda Investigative Site, Arlington, Texas, United States
Enveda Investigative Site, Houston, Texas, United States
Enveda Investigative Site, San Antonio, Texas, United States
Enveda Investigative Site, Norfolk, Virginia, United States
Study leads
Gurpreet Ahluwalia, PhD
Study Director
Enveda Therapeutics, Inc.